Mandy Berman
Known title: COO Back-Up and Emerging CareCIK: 0001662148
Associated companies
Transaction History
| BFAM | ▲ Buy | Grant | 7,260 | $0 | 3/4/2026 | View on chart |
| BFAM | ▲ Buy | Grant | 6,600 | $0 | 3/4/2026 | View on chart |
| BFAM | ▲ Buy | Grant | 3,847 | $0 | 2/24/2026 | View on chart |
| BFAM | ▼ Sell | Tax Withholding | 1,283 | $92K | 2/24/2026 | View on chart |
| BFAM | ▼ Sell | Tax Withholding | 2,430 | $174K | 2/24/2026 | View on chart |
| BFAM | ▲ Buy | Grant | 4,224 | $0 | 3/5/2025 | View on chart |
| BFAM | ▲ Buy | Grant | 4,756 | $0 | 3/4/2024 | View on chart |
| BFAM | ▲ Buy | Grant | 7,052 | $0 | 2/24/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
BMO Lowers Bright Horizons Price Target to $83
BMO Capital maintained its Outperform rating on Bright Horizons but lowered its price target to $83. This action follows a broader review of consumer discretionary education stocks after their second-quarter results. The new target sits below the current average analyst estimate of $88.11, reflecting a more conservative outlook for the company's near-term performance.
BMO Lowers Bright Horizons Price Target to $83. BMO Capital maintained its Outperform rating on Bright Horizons but lowered its price target to $83. This action follows a broader review of consumer discretionary education stocks after their second-quarter results. The new target sits below the current average analyst estimate of $88.11, reflecting a more conservative outlook for the company's near-term performance.